Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M154,402Revenue $M11,202Net Margin (%)27.5Z-Score8.0
Enterprise Value $M155,446EPS $1.8Operating Margin %40.4F-Score8
P/E(ttm))22.9Cash Flow Per Share $4.3Pre-tax Margin (%)37.6Higher ROA y-yY
Price/Book9.610-y EBITDA Growth Rate %0Quick Ratio2.2Cash flow > EarningsN
Price/Sales9.85-y EBITDA Growth Rate %8.2Current Ratio2.5Lower Leverage y-yY
Price/Cash Flow17.4y-y EBITDA Growth Rate %122ROA % (ttm)13.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)27.1Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,536ROI % (ttm)15.0Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDJulian Robertson 2014-06-30 Add2.98%$65.48 - $83.02
($77.76)
$ 102.1231%Add 28.55%443,911
GILDJoel Greenblatt 2014-06-30 Buy 0.48%$65.48 - $83.02
($77.76)
$ 102.1231%New holding, 466853 sh.466,853
GILDRay Dalio 2014-06-30 Add0.06%$65.48 - $83.02
($77.76)
$ 102.1231%Add 41.22%349,821
GILDRonald Muhlenkamp 2014-06-30 Reduce-0.59%$65.48 - $83.02
($77.76)
$ 102.1231%Reduce -24.63%144,715
GILDVanguard Health Care Fund 2014-06-30 Reduce-0.21%$65.48 - $83.02
($77.76)
$ 102.1231%Reduce -39.79%1,633,700
GILDGeorge Soros 2014-06-30 Sold Out -0.04%$65.48 - $83.02
($77.76)
$ 102.1231%Sold Out0
GILDMariko Gordon 2014-06-30 Reduce-0.02%$65.48 - $83.02
($77.76)
$ 102.1231%Reduce -35.57%11,654
GILDJulian Robertson 2014-03-31 Add0.59%$68.55 - $83.95
($78.44)
$ 102.1230%Add 7.91%345,320
GILDRay Dalio 2014-03-31 Add0.12%$68.55 - $83.95
($78.44)
$ 102.1230%Add 541.42%247,721
GILDGeorge Soros 2014-03-31 Buy 0.04%$68.55 - $83.95
($78.44)
$ 102.1230%New holding, 50000 sh.50,000
GILDJohn Burbank 2014-03-31 Buy 0.01%$68.55 - $83.95
($78.44)
$ 102.1230%New holding, 3619 sh.3,619
GILDMario Gabelli 2014-03-31 Add$68.55 - $83.95
($78.44)
$ 102.1230%Add 31.65%44,240
GILDDaniel Loeb 2014-03-31 Sold Out -1.9%$68.55 - $83.95
($78.44)
$ 102.1230%Sold Out0
GILDJohn Griffin 2014-03-31 Sold Out -0.48%$68.55 - $83.95
($78.44)
$ 102.1230%Sold Out0
GILDVanguard Health Care Fund 2014-03-31 Reduce-0.46%$68.55 - $83.95
($78.28)
$ 102.1230%Reduce -41.41%2,713,300
GILDJulian Robertson 2013-12-31 Add1.52%$58.9 - $75.2
($69.65)
$ 102.1247%Add 25.84%320,001
GILDDaniel Loeb 2013-12-31 Add1.27%$58.9 - $75.2
($69.65)
$ 102.1247%Add 200%1,500,000
GILDRay Dalio 2013-12-31 Buy 0.02%$58.9 - $75.2
($69.65)
$ 102.1247%New holding, 38621 sh.38,621
GILDJohn Griffin 2013-12-31 Reduce-1.02%$58.9 - $75.2
($69.65)
$ 102.1247%Reduce -68.21%620,000
GILDJohn Hussman 2013-12-31 Sold Out -0.86%$58.9 - $75.2
($69.65)
$ 102.1247%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
GILD Joel Greenblatt 2014-06-30466,8530.030.48New Buy
GILD Ray Dalio 2014-06-30349,8210.020.22+41.22%
GILD Julian Robertson 2014-06-30443,9110.0313.4+28.55%
GILD Mario Gabelli 2014-06-3049,17000.02+11.14%
GILD John Burbank 2014-06-303,77400.01+4.28%
GILD Jean-Marie Eveillard 2014-06-3040000
GILD Ronald Muhlenkamp 2014-06-30144,7150.012.1-24.63%
GILD Mariko Gordon 2014-06-3011,65400.04-35.57%
GILD Vanguard Health Care Fund 2014-06-301,633,7000.110.36-39.79%
GILD George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Washington Robin LEVP, CFO 2014-08-14Sell33,556$95.565.47view
Carter Paul RutherfordEVP Commercial Ops 2014-08-08Sell16,728$91.5810.06view
Whitley Richard JamesDirector 2014-08-01Sell5,000$9110.76view
Washington Robin LEVP, CFO 2014-08-01Sell30,600$91.4810.18view
Alton Gregg HEVP, Corp & Med Affairs 2014-08-01Sell33,000$91.6210.01view
MARTIN JOHN CChairman and CEO 2014-08-01Sell140,625$91.5310.12view
MOORE NICHOLAS GDirector 2014-07-28Sell45,000$90.5611.3view
Cogan John FrancisDirector 2014-07-21Sell5,000$89.6712.4view
Carter Paul RutherfordEVP Commercial Ops 2014-07-08Sell16,728$86.4516.59view
Alton Gregg HEVP, Corp & Med Affairs 2014-07-01Sell33,000$84.1219.82view

Press Releases about GILD :

    Quarterly/Annual Reports about GILD:

    News about GILD:

    Articles On GuruFocus.com
    New Magic Formula Stocks From Joel Greenblatt: CBI, DAL, GILD, MNST, ROST, LUV Aug 18 2014 
    Julian Robertson Buys Tableau Software, Facebook, Netflix, Sells Ulta Salon, EBay, EQT Aug 14 2014 
    Creating Cures And Dividends Where None Existed Before With Gilead Sciences Jul 26 2014 
    Analyzing Why Gilead Sciences is Still a Great Buy Jul 24 2014 
    Why AbbVie Looks Like a Sell Jul 18 2014 
    Why Gilead Sciences Will Grow to $100 Jul 18 2014 
    Weekly CEO Sells Highlight: Karopharm Therapeuticcs Inc., Methode Electronics Inc., Gilead Sciences Jul 06 2014 
    Weekly CFO Sells Highlight: Facebook Inc, Workday Inc, Gilead Sciences Inc. Jun 23 2014 
    Weekly Insider Sells Highlight: FB, NFLX, WDAY, GILD Jun 22 2014 
    Julian Robertson Likes Uber, Google, Gilead, Stan Druckenmiller Jun 12 2014 


    More From Other Websites
    hVIVO HCM of GS-5086 in RSV for Gilead Sciences Aug 21 2014
    The New All-Time Highs... Aug 20 2014
    Gilead Sciences: 'Risk of HCV Price War Overblown,' Bernstein Says Aug 20 2014
    Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus Aug 20 2014
    Top 3 Sector ETFs' Recent History Aug 19 2014
    The All-Time New Highs... Aug 19 2014
    10 S&P 500 companies growing faster than their rivals Aug 19 2014
    Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session Aug 19 2014
    Achillion Pharmaceuticals Up On Buyout Rumors Aug 18 2014
    Jazz, Celgene Lead Top 4 Drugmaker Profit Margins Aug 18 2014
    Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up Aug 18 2014
    [video] Cramer: Market about Russia-Ukraine Aug 18 2014
    Gilead, Vipshop Lead Top 4 IBD 50 Stocks In EPS Gains Aug 16 2014
    Biotech Leader Gilead Sciences Scores Sovaldi Win Aug 15 2014
    Gilead Wins Sovaldi Dispute With Roche, U.K. Nod Aug 15 2014
    [video] Stock Pops & Drops: ADSK, MNST, JCP, GILD Aug 15 2014
    Markets Close The Week On Negative Note As Ukraine Worries Mount Aug 15 2014
    Stocks close mixed on renewed geopolitical concerns Aug 15 2014
    [$$] U.K. Drug Panel Backs Sovaldi Aug 15 2014
    Gilead Sciences: Arbitrator Removes 'Doomsday Scenario' Aug 15 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide